Hip Protectors: Are They Worth it?

Verfasser / Beitragende:
[Luisella Cianferotti, Caterina Fossi, Maria Brandi]
Ort, Verlag, Jahr:
2015
Enthalten in:
Calcified Tissue International, 97/1(2015-07-01), 1-11
Format:
Artikel (online)
ID: 605520399
LEADER caa a22 4500
001 605520399
003 CHVBK
005 20210128100735.0
007 cr unu---uuuuu
008 210128e20150701xx s 000 0 eng
024 7 0 |a 10.1007/s00223-015-0002-9  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00223-015-0002-9 
245 0 0 |a Hip Protectors: Are They Worth it?  |h [Elektronische Daten]  |c [Luisella Cianferotti, Caterina Fossi, Maria Brandi] 
520 3 |a Hip fractures are one of the most serious conditions in frail elderly subjects, greatly increasing morbidity and mortality, and decreasing healthy life years. Since their first introduction on the market, hip protectors have been revealed to be a potential preventive measure for hip fractures, in addition to other well-known recognized medical interventions and rehabilitation procedures. However, randomized controlled trials have given contradictory results regarding their efficacy. Moreover, little data are available on the cost effectiveness of hip protectors. Adherence is a major problem in assessing the effectiveness of hip protectors in preventing fractures. Indeed, there is a lack of general consensus on a standard definition and quantitative objective estimation of adherence to hip protectors, along with still scarce evidence on specific interventions on how to ameliorate it. From what is known so far, it seems reasonable to advise the use of hip protectors in aged care facilities, since recent pooled analyses have suggested their efficacy in this setting. The introduction of sensors combined with hip protectors will probably address this issue, both for monitoring and optimizing compliance, especially in elderly people. In the meantime, new, well-designed studies following specific guidelines are strongly encouraged and needed. In particular, studies in community-dwelling elderly individuals at high risk of first or further fragility fractures are required. The optimization of the tested devices in a preclinical setting according to international standard biomechanical testing is necessary. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Hip fracture  |2 nationallicence 
690 7 |a Osteoporosis  |2 nationallicence 
690 7 |a Frailty  |2 nationallicence 
690 7 |a Falls  |2 nationallicence 
690 7 |a Nursing homes  |2 nationallicence 
690 7 |a Effectiveness  |2 nationallicence 
700 1 |a Cianferotti  |D Luisella  |u Department of Surgery and Translational Medicine, Section of Endocrinology, Unit of Bone and Mineral Metabolism, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy  |4 aut 
700 1 |a Fossi  |D Caterina  |u Department of Surgery and Translational Medicine, Section of Endocrinology, Unit of Bone and Mineral Metabolism, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy  |4 aut 
700 1 |a Brandi  |D Maria  |u Department of Surgery and Translational Medicine, Section of Endocrinology, Unit of Bone and Mineral Metabolism, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy  |4 aut 
773 0 |t Calcified Tissue International  |d Springer US; http://www.springer-ny.com  |g 97/1(2015-07-01), 1-11  |x 0171-967X  |q 97:1<1  |1 2015  |2 97  |o 223 
856 4 0 |u https://doi.org/10.1007/s00223-015-0002-9  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a review-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00223-015-0002-9  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Cianferotti  |D Luisella  |u Department of Surgery and Translational Medicine, Section of Endocrinology, Unit of Bone and Mineral Metabolism, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Fossi  |D Caterina  |u Department of Surgery and Translational Medicine, Section of Endocrinology, Unit of Bone and Mineral Metabolism, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Brandi  |D Maria  |u Department of Surgery and Translational Medicine, Section of Endocrinology, Unit of Bone and Mineral Metabolism, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Calcified Tissue International  |d Springer US; http://www.springer-ny.com  |g 97/1(2015-07-01), 1-11  |x 0171-967X  |q 97:1<1  |1 2015  |2 97  |o 223